These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 15373800)
21. BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study. Casula M; Colombino M; Satta MP; Cossu A; Ascierto PA; Bianchi-Scarrà G; Castiglia D; Budroni M; Rozzo C; Manca A; Lissia A; Carboni A; Petretto E; Satriano SM; Botti G; Mantelli M; Ghiorzo P; Stratton MR; Tanda F; Palmieri G; J Clin Oncol; 2004 Jan; 22(2):286-92. PubMed ID: 14722037 [TBL] [Abstract][Full Text] [Related]
22. Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors. Scherer D; Rachakonda PS; Angelini S; Mehnert F; Sucker A; Egberts F; Hauschild A; Hemminki K; Schadendorf D; Kumar R J Invest Dermatol; 2010 Dec; 130(12):2844-8. PubMed ID: 20720566 [No Abstract] [Full Text] [Related]
23. SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant. Tsavachidou D; Coleman ML; Athanasiadis G; Li S; Licht JD; Olson MF; Weber BL Cancer Res; 2004 Aug; 64(16):5556-9. PubMed ID: 15313890 [TBL] [Abstract][Full Text] [Related]
24. B-RAF and melanocytic neoplasia. Gill M; Celebi JT J Am Acad Dermatol; 2005 Jul; 53(1):108-14. PubMed ID: 15965430 [TBL] [Abstract][Full Text] [Related]
25. BRAF mutations in conjunctival melanoma. Gear H; Williams H; Kemp EG; Roberts F Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2484-8. PubMed ID: 15277467 [TBL] [Abstract][Full Text] [Related]
26. Lack of BRAF mutations in Spitz nevi. Gill M; Renwick N; Silvers DN; Celebi JT J Invest Dermatol; 2004 May; 122(5):1325-6. PubMed ID: 15140238 [No Abstract] [Full Text] [Related]
27. Suppression of BRAF(V599E) in human melanoma abrogates transformation. Hingorani SR; Jacobetz MA; Robertson GP; Herlyn M; Tuveson DA Cancer Res; 2003 Sep; 63(17):5198-202. PubMed ID: 14500344 [TBL] [Abstract][Full Text] [Related]
30. BRAF as a potential therapeutic target in melanoma and other malignancies. Tuveson DA; Weber BL; Herlyn M Cancer Cell; 2003 Aug; 4(2):95-8. PubMed ID: 12957284 [No Abstract] [Full Text] [Related]